PIXYL

PIXYL is a French MedTech company that specializes in artificial intelligence solutions for medical imaging, focusing on brain MRI analysis. The company aims to enhance patient care by developing AI-powered software that provides rapid insights from MRI scans, particularly for neuroinflammatory and neurodegenerative disorders like multiple sclerosis. Its flagship product, Pixyl.Neuro, is an FDA-cleared and CE-marked medical device that utilizes proprietary AI algorithms to detect anomalies in brain MR images. The software allows for quick analysis, typically in under five minutes, and integrates into clinical workflows to support diagnostic and treatment decisions. Key features include brain segmentation, volume quantification, lesion classification, and longitudinal analysis. PIXYL collaborates with leading healthcare organizations and has gained recognition for its predictive AI solutions. Its technology is used in over 100 medical centers across more than 12 countries, serving radiologists, neurologists, and healthcare institutions dedicated to improving diagnostic accuracy and patient outcomes in neurological diseases.

• Employees 21
• Founded 2015
• Total Funding $668300